Adverum Biotechnologies Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $29.70 on 02/08/24, and the lowest price during that time was $6.38, recorded on 06/20/24.
52-week price history of ADVM Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Adverum Biotechnologies Inc’s current trading price is -72.49% away from its 52-week high, while its distance from the 52-week low is 28.06%. The stock’s price range for this period has remained between $6.38 and $29.70. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.56 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.41 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Adverum Biotechnologies Inc (ADVM) has experienced a quarterly decline of -26.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 169.61M and boasts a workforce of 121 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.96, with a change in price of -11.33. Similarly, Adverum Biotechnologies Inc recorded 344,108 in trading volume during the last 100 days, posting a change of -58.10%.
ADVM Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ADVM stands at 0.41. Similarly, the long-term debt-to-equity ratio is also 0.35.
ADVM Stock Stochastic Average
As of today, the raw stochastic average of Adverum Biotechnologies Inc over the last 50 days is at 40.87%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 46.61%. Further, the company’s Stochastic %K and %D values for the last 20 days were 71.29% and 82.45%, respectively.
ADVM Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 8.53% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -3.87%. Over the past 30 days, the price of ADVM has fallen by 23.98%. And in the last five days, it has surged by 3.29%.
